Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (6935)	8/13/1998 10:55:00 AM
From: Edward Paule	Read Replies (1) \| Respond to of 17367

I may regret this move latter, but for now.... I just sold the only stock I have that hasn't taken a beating in the current market correction (ICOS) and used the proceeds to buy more XOMA. ICOS is one of the few biotech stocks I consider to be overvalued. Most biotech stocks, like XOMA, are undervalued. Since ICOS is 3 years away before any potential product approval and they're starting to run low on cash, I should be able to get back into ICOS next year or so at a more attractive price. In the meantime, go Xoma. - Ed.